rs386833792
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_003982.4(SLC7A7):c.14C>T(p.Thr5Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
SLC7A7
NM_003982.4 missense
NM_003982.4 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: -0.344
Publications
1 publications found
Genes affected
SLC7A7 (HGNC:11065): (solute carrier family 7 member 7) The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011]
SLC7A7 Gene-Disease associations (from GenCC):
- lysinuric protein intoleranceInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-22813385-G-A is Pathogenic according to our data. Variant chr14-22813385-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 56344.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP4
Computational evidence support a benign effect (MetaRNN=0.2850808). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A7 | NM_003982.4 | c.14C>T | p.Thr5Ile | missense_variant | Exon 2 of 10 | ENST00000674313.1 | NP_003973.3 | |
SLC7A7 | NM_001126105.3 | c.14C>T | p.Thr5Ile | missense_variant | Exon 3 of 11 | NP_001119577.1 | ||
SLC7A7 | NM_001126106.4 | c.14C>T | p.Thr5Ile | missense_variant | Exon 3 of 11 | NP_001119578.1 | ||
SLC7A7 | XM_011537299.2 | c.14C>T | p.Thr5Ile | missense_variant | Exon 2 of 10 | XP_011535601.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 35
GnomAD4 exome
Cov.:
35
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Lysinuric protein intolerance Pathogenic:1Uncertain:1
May 22, 2025
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T;T;.;T;.;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;.;.;T;T;T;T;T;T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N;N;N;.;.;.;.;.;.;.;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;D;D
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
T;T;T;T;T;.;.;.;.;.;.;T;.
Polyphen
B;B;B;B;B;.;.;.;.;.;.;.;.
Vest4
MutPred
Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);Loss of phosphorylation at V5 (P = 0.0223);
MVP
MPC
0.21
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.